نتائج البحث

Safety of interferon β-1a for treatment of COVID-19： a real-world study based on FAERS database

• Authors : YANG Rongqing; GAO Yongqing; HU Fangyuan

Subjects: interferon β-1a; coronavirus disease 2019; information component

• Source: Shanghai yufang yixue, Vol 35, Iss 6, Pp 549-554 (2023)

تفاصيل العنوان

BRAVO Study: Laquinimod Double-blind Placebo-controlled Study in Participants With Relapsing-Remitting Multiple Sclerosis (RRMS) With a Rater Blinded Reference Arm of Interferon β-1a (Avonex®) (BRAVO)

• Source: A Multinational, Multicenter, Randomized, Parallel-Group Study Performed in Subjects With Relapsing-Remitting Multiple Sclerosis (RRMS) to Assess the Efficacy, Safety and Tolerability of Laquinimod

تفاصيل العنوان

Interferon β-1a ring prophylaxis to reduce household transmission of SARS-CoV-2: a cluster randomised clinical trialResearch in context

• Authors : José A. Castro-Rodriguez; Eleanor N. Fish; Samuel T. Montgomery

Subjects: SARS-CoV-2; COVID-19; Interferon

• Source: EClinicalMedicine, Vol 62, Iss , Pp 102082- (2023)

تفاصيل العنوان

Temporal evolution of new T1-weighted hypo-intense lesions and central brain atrophy in patients with a first clinical demyelinating event treated with subcutaneous interferon β-1a

• Authors : Vrenken, H; Battaglini, M; de Vos, ML

Subjects: Black-hole lesions; Brain atrophy; First clinical demyelinating event

• Source: Journal of Neurology (2023) (In press).

تفاصيل العنوان

Interferon β-1a subcutaneously 3 times/week clinical outcome in relapsing multiple sclerosis in Finland

• Authors : Elina Järvinen; Annukka Murtonen; Melina Tervomaa

Subjects: Multiple sclerosis, Interferon β-1a s.c tiw, Disability progression, EDSS; Medicine; Internal medicine

• Source: Neurology International, Vol 11, Iss 4 (2019)

تفاصيل العنوان

Subjective patient-reported versus objective adherence to subcutaneous interferon β-1a in multiple sclerosis using RebiSmart®: the CORE study

• Authors : Chiara Zecca; Giulio Disanto; Sarah Mühl

Subjects: Multiple sclerosis; RebiSmart®; Autoinjector

• Source: BMC Neurology, Vol 17, Iss 1, Pp 1-5 (2017)

تفاصيل العنوان

Interferon β-1a and Atorvastatin in the Treatment of Multiple Sclerosis

• Authors : Keyvan Ghasami; Fardin Faraji; Masoud Fazeli

Subjects: Atorvastatin; Cytokines; Expanded Disability Status Scale Scores (EDSS)

• Source: Iranian Journal of Immunology, Vol 13, Iss 1, Pp 16-26 (2016)

تفاصيل العنوان

Longitudinal changes in social functioning in mildly disabled patients with relapsing—remitting multiple sclerosis receiving subcutaneous interferon β-1a: results from the COGIMUS (COGnitive Impairment in MUltiple Sclerosis) study (II)

• Authors : Patti, Francesco; Amato, Maria Pia; Trojano, Maria

• Source: Quality of Life Research, 2012 Sep 01. 21(7), 1111-1121.

تفاصيل العنوان

A Prospective Multicenter Study for Assessing MusiQoL Validity among Arabic-Speaking MS Patients Treated with Subcutaneous Interferon β-1a.

• Authors : Al Jumah, Mohammed¹ (AUTHOR); Kojan, Suleiman² (AUTHOR); Alroughani, Raed³ (AUTHOR)

• Source: Multiple Sclerosis International. 3/2/2021, p1-7. 7p.

تفاصيل العنوان

Subcutaneous interferon β-1a administration by electronic auto-injector is associated with high adherence in patients with relapsing remitting multiple sclerosis in a real-life study

• Authors : Elina Järvinen; Juha Multanen; Sari Atula

Subjects: Relapsing remitting multiple sclerosis; Adherence; Auto-injector

• Source: Neurology International, Vol 9, Iss 1 (2017)

تفاصيل العنوان